Connect with us


Will COVID Boosters Prevent Another Wave? Scientists Aren’t So Sure.

News Agencies



A Covid-19 vaccine event in Maywood, Ill., Sept. 13, 2022. (Jamie Kelter Davis/The New York Times)

A Covid-19 vaccine event in Maywood, Ill., Sept. 13, 2022. (Jamie Kelter Davis/The New York Times)

As winter looms and Americans increasingly gather indoors without masks or social distancing, a medley of new coronavirus variants is seeding a rise in cases and hospitalizations in counties across the nation.

The Biden administration’s plan for preventing a national surge depends heavily on persuading Americans to get updated booster shots of the Pfizer-BioNTech and Moderna vaccines. Now some scientists are raising doubts about this strategy.

Sign up for The Morning newsletter from the New York Times

Older adults, immunocompromised people and pregnant women should get the booster shots, because they offer extra protection against severe disease and death, said John Moore, a virus expert at Weill Cornell Medicine in New York.

But the picture is less clear for healthy Americans who are middle-aged and younger. They are rarely at risk of severe illness or death from COVID, and at this point most have built immunity through multiple vaccine doses, infections or both.

The newer variants, called BQ.1 and BQ.1.1, are spreading quickly, and boosters seem to do little to prevent infections with these viruses, as they are excellent evaders of immunity.

“If you’re at medical risk, you should get boosted, or if you’re at psychological risk and worrying yourself to death, go and get boosted,” Moore said. “But don’t believe that will give you some kind of amazing protection against infection, and then go out and party like there’s no tomorrow.”

The most recent boosters are “bivalent,” targeting both the original version of the coronavirus and the omicron variants circulating earlier this year, BA.4 and BA.5. Only about 12% of adults have opted for the latest shot.

In an interview, Dr. Peter Marks, the Food and Drug Administration’s top vaccine regulator, acknowledged the limitations of the available data on the updated boosters.

“It’s true, we’re not sure how well these vaccines will do yet against preventing symptomatic disease,” he said, particularly as the newer variants spread.

But, Marks added, “even modest improvements in vaccine response to the bivalent boosters could have important positive consequences on public health. Given the downside is pretty low here, I think the answer is we really advocate people going out and consider getting that booster.”

Diminishing returns from tinkering with the Pfizer-BioNTech and Moderna vaccines call for a new approach to protecting Americans altogether, Moore and other experts said. A universal vaccine that targets parts of the coronavirus that do not mutate would be ideal, for example. A nasal vaccine might be better at preventing infections than an injected one.

“Chasing variants by tweaking the mRNA vaccines is not a sustainable strategy,” Moore said. “There’s a need for better vaccine designs, but that needs a change of attitude at the government level.”

Recently, Pfizer-BioNTech and Moderna reported that their bivalent shots yielded antibody levels in study participants that were four to six times higher than those produced by the original vaccine.

But the companies were measuring antibodies against BA.4 and BA.5, not the rapidly accelerating BQ.1 and BQ.1.1 variants. A spate of preliminary research suggests that the updated boosters, introduced in September, are only marginally better than the original vaccines at protecting against the newer variants — if at all.

The studies are small, based on laboratory tests, and have not yet been vetted for publication in a scientific journal. But results from several teams generally agree.

“It’s not likely that any of the vaccines or boosters, no matter how many you get, will provide substantial and sustained protection against acquisition of infection,” said Dr. Dan Barouch, head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, who helped develop the Johnson & Johnson vaccine.

Designing a vaccine for an evolving virus is a formidable challenge. Pfizer, Moderna and federal regulators had to choose which coronavirus variants to target earlier this year, so enough vaccine could be manufactured by the fall.

But BA.4 has all but disappeared. BA.5 now accounts for less than 30% of cases and is swiftly receding. BQ.1, on the other hand, has sent numbers soaring in Europe. That virus and its close relative, BQ.1.1, now account for 44% of U.S. coronavirus infections.

In recent research, Barouch’s team found that BQ.1.1 is roughly seven times as resistant to the body’s immune defenses as BA.5, and 175 times more so than the original coronavirus.

“It has the most striking immune escape, and it’s also growing the most rapidly,” he said.

BQ.1 is expected to behave similarly.

By now, most Americans have some degree of immunity to the coronavirus, and it does not surprise scientists that the variant that best evades the body’s immune response is likely to outrun its rivals.

The new bivalent booster increases antibody levels, as any booster would be expected to do.

But the fact that the dose is bivalent may not mean much. In August, a modeling study by immunologists in Australia suggested that any booster at all would confer additional protection, but that a variant-specific shot was unlikely to be more effective than the original vaccine.

“The bulk of the benefit is from the provision of a booster dose, irrespective of whether it is a monovalent or bivalent vaccine,” the World Health Organization cautioned last month.

Studies have shown that most of the antibodies elicited by a vaccine targeting BA.5, for example, still recognize only the original virus.

That’s because of a phenomenon called “immune imprinting,” in which the body preferentially repeats its immune response to the first variant it encountered, despite being alerted to a newer variant.

“It’s easier for the immune system to go back to something that it has already seen,” said Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai in New York. (Krammer has served as a consultant for Pfizer.)

Some experts have suggested that the booster shots should have been “monovalent,” simply targeting the recent variants. Instead, the manufacturers effectively halved the crucial omicron-specific component of the new booster, undermining the shot’s effectiveness, they said.

But Krammer was more sanguine about the boosters overall, despite recent research. The new studies looked at the immune response soon after vaccination, and the response may improve over time, he said.

“We will see with larger studies and studies at a later time point if there is a good or a significant benefit, but I think it’s certainly not worse,” he added. “I don’t see much risk when you get the vaccine, so you might as well get the benefit.”

There may be ways to circumvent immune imprinting — perhaps with a second dose of a bivalent vaccine that builds on the immune response after the first, much as the second dose of the initial vaccine series cemented protection.

“What we need to do right now to get us through the next few months when I think we are in yet another wave of incipient wave of COVID,” Marks said. “And then we need to look forward, and lean into how we’re going to do things differently moving forward.”

The FDA authorized the boosters for use at least two months after a previous dose or infection. But boosting again so soon may backfire, some studies suggest. Lengthening the interval between boosts to five or six months may be more effective, giving the immune system more time to refine its response.

Whatever the timing, adding yet another shot to the regimen seems unlikely to motivate Americans to opt for the immunization.

“Each new booster we roll out is going to have a lower and lower uptake, and we’re already pretty close to the floor,” said Gretchen Chapman, an expert in health behavior at Carnegie Mellon University in Pittsburgh.

The Biden administration may have no choice but to promote boosters given the lifting of other precautions, Chapman said. But most people make decisions based on what others in their social network do, or what their political and community leaders recommend, not on esoteric scientific data, she noted.

“We should not spend a lot of political capital trying to get people to get this bivalent booster, because the benefits are limited,” she added. “It’s more important to get folks who never got the initial vaccine series vaccinated than to get people like me to get their fifth shot.”

The Biden administration may have better luck persuading people to get boosters if other vaccines, such as Novavax or J&J, were available for that purpose, she added. That may be particularly true for people who have hesitated to get a booster shot because they have had a strong reaction to an mRNA vaccine.

Even from a scientific perspective, it may make more sense to diversify the body’s antibody response with different vaccines than to continue to roll out versions of the mRNA vaccines, some experts said.

Marks said the FDA may recommend Novavax as a second booster after reviewing the data. Until then, that vaccine is authorized only as a first booster for people who are unwilling to, or cannot, get an mRNA vaccine.

That rule “is completely ridiculous,” Moore said. “If the FDA’s goal is to increase vaccine uptake and boost immunity in the American population, why is it putting restrictions like this?”

© 2022 The New York Times Company

Continue Reading

Breaking News


Editor Pick’s

Latest Entertainment

Entertainment8 hours ago

Dua Lipa shares recording studio photos with Rolling Stones frontman Mick Jagger

Dua Lipa shares recording studio photos with Mick Jagger. (Photo: Michael Tullberg/Getty Images) Is there a Dua Lipa and Rolling...

Entertainment8 hours ago

Dwayne Johnson Says He’s Grateful for Thanksgiving with Family: ‘We Count Our Blessings’

LOS ANGELES, CALIFORNIA – NOVEMBER 03: (L-R) Ata Johnson and Dwayne Johnson attend the World Premiere of Netflix’s “Red Notice”...

Entertainment8 hours ago

Queen Elizabeth Knew Her Time Was Running Short, ‘Had No Regrets’ Before Her Death, Book Says

FEBRUARY 02: Queen Elizabeth II is photographed at Sandringham House to commemorate Accession Day, marking the start of Her Majesty’s...

Entertainment8 hours ago

Pregnant Chrissy Teigen and John Legend Celebrate Thanksgiving with Luna & Miles Ahead of Next Baby

chrissy teigen, john legend Chrissy Teigen/Instagram Chrissy Teigen and John Legend have lots to be thankful for this Thanksgiving. The...

Entertainment10 hours ago

Irene Cara, Oscar-winning ‘Flashdance’ singer and Fame star, dies at 63

Irene Cara, the Oscar-winning singer best known for performing the theme songs to the legendary films Flashdance and Fame, has...

Entertainment10 hours ago

Bob Dylan Says He ‘Regrets’ an ‘Error in Judgment’ in Selling Machine-Signed Art and Books: ‘I Want to Rectify It Immediately’

Bob Dylan issued a rare public statement Friday night to admit that he “regrets” having made “an error in judgment”...

Entertainment11 hours ago

Kimberly Stewart Shares Sweet Thanksgiving Photo of Her and Benicio Del Toro’s Daughter: ‘Thankful’ Kimberly Stewart/Instagram Kimberly Stewart/Instagram Kimberly Stewart celebrated Thanksgiving with her mini-me by her side. The actress, 43, spent the...

Entertainment17 hours ago

Madonna Shares Rare Snap With All Six Of Her Children As They Celebrate Thanksgiving Together

Madonna has revealed she had a lot to be grateful for this Thanksgiving after spending the day with all six...

Latest Sports

Sports1 hour ago

How can USA qualify for the World Cup last 16?

How can the USA qualify for the last 16 of the World Cup and what do they need against Iran...

Sports1 hour ago

College football scores: USC hosts Notre Dame

USC still has College Football Playoff aspirations, but they have to get past No. 15 Notre Dame in order to...

Sports2 hours ago

Nebraska signs Matt Rhule to 8-year deal as football coach

After six straight losing seasons and more than 20 years removed from its 1990s heyday, Nebraska is turning to Matt...

Sports2 hours ago

Jim Harbaugh discusses the origins of the trick play against Ohio State

Neither were the coaching staff, as head coach Jim Harbaugh told reporters after the game that the Wolverines had "emptied...

Sports2 hours ago

Ja Morant tweets about quiet Klay Thompson critics with Warriors’ star shining

Ja Morant doesn't usually side with the Warriors, but on Friday night, that changed.

Sports3 hours ago

Syracuse’s Judah Mintz ejected after slapping Bryant guard in the face, sparking wild altercation

Four players and three assistant coaches were ejected after Syracuse's Judah Mintz and Bryant's Doug Edert got into it early...

Sports3 hours ago

‘Ryan Day is playing checkers.’ Ohio State football loses to Michigan | Fan reactions

Here's how fans are responding to the Buckeyes' latest loss on social media.

Sports4 hours ago

Everything Jim Harbaugh said after Michigan’s win over Ohio State

Get an annual subscription to M&BR for only $22! Use code RIVALS22 On how proud he is of the teamSo...

Technology Hot News

Is Elon Musk Really Going to Buy Twitter? Is Elon Musk Really Going to Buy Twitter?
Technology1 month ago

Is Elon Musk Really Going to Buy Twitter?

Elon Musk, the owner of the electric car company Tesla, CEO of SpaceX, and the richest man in the world,...

WhatsApp services were affected across Pakistan, restored after 2 hours WhatsApp services were affected across Pakistan, restored after 2 hours
Technology1 month ago

WhatsApp services were affected across Pakistan, restored after 2 hours

WhatsApp services were affected in various countries of the world, including Pakistan, and India due to this users were facing...

Bitcoin vs Litecoin: A guide to understanding cryptocurrencies Bitcoin vs Litecoin: A guide to understanding cryptocurrencies
Technology1 month ago

Bitcoin vs Litecoin: A guide to understanding cryptocurrencies

Cryptocurrencies currently occupy an odd place in society. They are no longer the super niche bizarre currency beloved by tech...

Personal data of people is selling on Google Play and Google Ads Personal data of people is selling on Google Play and Google Ads
Editor Picks2 months ago

Personal data of people are sold on Google Play and Google Ads

It’s been two to three years since Google has been unknowingly hosting multiple apps from malicious actors who sell personal...

Protonmail is down a second time in the past 24 hours Protonmail is down a second time in the past 24 hours
Technology5 months ago

Protonmail is down a second time in the past 24 hours

An end-to-end encrypted email service Protonmail is down a second time in the past 24 hours, netizens reported on social...

What's better for the student: a tablet or a laptop What's better for the student: a tablet or a laptop
Technology6 months ago

What’s better for the student: a tablet or a laptop

Some analysts argue that computers have outlived their usefulness. There is some truth in this: PC and laptop sales are...

Tesla founder Elon Musk holds the Twitter deal temporary Tesla founder Elon Musk holds the Twitter deal temporary
Technology7 months ago

Tesla founder Elon Musk holds the Twitter deal temporary

USA: Elon Musk, the founder of companies like Tesla and SpaceX, can actually buy anything in the world. Last month,...

How Zafar Supari is utilizing his ability on Snapchat? How Zafar Supari is utilizing his ability on Snapchat?
Technology7 months ago

How Zafar Supari is utilizing his ability on Snapchat?

Pakistan: Zafar Supari a public figure, businessman, and social media sensation has crossed one hundred thirty-three thousand 133k subscribers on...